| 前收市價 | 94.41 |
| 開市 | 94.11 |
| 買盤 | 91.37 x 900 |
| 賣出價 | 92.27 x 800 |
| 今日波幅 | 91.47 - 94.33 |
| 52 週波幅 | 70.89 - 95.72 |
| 成交量 | |
| 平均成交量 | 12,421,906 |
| 市值 | 232.372B |
| Beta 值 (5 年，每月) | 0.37 |
| 市盈率 (最近 12 個月) | 16.77 |
| 每股盈利 (最近 12 個月) | 5.48 |
| 業績公佈日 | 2022年7月28日 |
| 遠期股息及收益率 | 2.76 (3.00%) |
| 除息日 | 2022年6月14日 |
| 1 年預測目標價 | 97.61 |
- InvestorPlace
3 Dow Stocks to Buy for a Bear Market
A new battle with inflation has thrown Dow stocks into a bear market. At last week’s low, the Dow Jones Industrial Index was down 19.8% from its January peak – close enough to trigger the bear market alarm bells for all but the strictest of market watchers. Besides, all other indexes have already sunk deep into bear country. With a volatile and treacherous environment now upon us, it’s worth asking which are the best Dow stocks to buy? Of course, the answer depends on what you’re looking for, so
- Benzinga
Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ
Merck & Co Inc (NYSE: MRK) is pushing forward with a potential deal for Seagen Inc (NASDAQ: SGEN), Wall Street Journal reported, citing people familiar with the matter. The Journal mentioned that the deal could be one of the largest takeovers of the year. The Wall Street Journal reported last week that Merck was in talks to buy Seagen, which would bolster the pharma giant's cancer-drug portfolio, but no agreement was imminent. Related: SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen
